Skip to main navigation Skip to search Skip to main content

Human Brain Organoid Platform for Neuroengineering Optical Theranostics in Neonatal Sepsis

  • Sneha S. Karanth
  • , Radhika Mujumdar
  • , Jagdish P. Sahoo
  • , Abhijit Das
  • , Michal K. Stachowiak
  • , Anirban Dutta
  • SUNY Buffalo
  • Siksha ‘O’ Anusandhan University
  • The Walton Centre NHS Foundation Trust

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations

Abstract

Early-onset neonatal sepsis can increase the risk of hypoxic-ischemic encephalopathy (HIE) that can worsen the patient’s prognosis. We investigated neurometabolic coupling (NMC) in five full-term neonates with HIE and sepsis that was found lower than the other five with HIE only. We hypothesized that transcranial photobiomodulation might upregulate cerebral oxygen metabolism, which may restore NMC. We developed a human brain organoid platform to evaluate the effects of photobiomodulation around 810 nm on the Cytochrome-C Oxidase (CCO) activity and electrophysiology. We found that 10 min of photobiomodulation increased CCO activity, pH, and temperature while decreased the spectral exponent in 1–40 Hz from electrophysiology data. For future work, it is postulated that photobiomodulation at ~810 nm may ameliorate metabolic acidosis and dysfunctional NMC in neonatal sepsis, thereby reducing the risk of HIE transition.

Original languageEnglish
Title of host publicationBiosystems and Biorobotics
PublisherSpringer Science and Business Media Deutschland GmbH
Pages753-757
Number of pages5
DOIs
StatePublished - 2022

Publication series

NameBiosystems and Biorobotics
Volume28
ISSN (Print)2195-3562
ISSN (Electronic)2195-3570

Fingerprint

Dive into the research topics of 'Human Brain Organoid Platform for Neuroengineering Optical Theranostics in Neonatal Sepsis'. Together they form a unique fingerprint.

Cite this